ArticleTheScientificWorldJournal2013

Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells.

Lei-qing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.